Ian T. Bothwell - 21 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
ZEOX
Transactions as of
21 May 2021
Net transactions value
-$37,550
Form type
4
Filing time
25 May 2021, 21:45:41 UTC
Previous filing
17 May 2021
Next filing
28 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $9,000 -50,000 -0.03% $0.1800 149,318,726 21 May 2021 Direct
transaction OCEL Common Stock Sale $9,000 -50,000 -0.03% $0.1800 149,268,726 24 May 2021 Direct
transaction OCEL Common Stock Sale $9,550 -50,000 -0.03% $0.1910 149,218,726 25 May 2021 Direct
transaction OCEL Common Stock Sale $10,000 -50,000 -0.03% $0.2000 149,168,726 25 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.